NDC 0074-7269
Gengraf
Cyclosporine
Gengraf is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Cyclosporine.
| Product ID | 0074-7269_246333e8-da30-bcc3-077e-e73865a61b99 |
| NDC | 0074-7269 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Gengraf |
| Generic Name | Cyclosporine |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-05-25 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA065025 |
| Labeler Name | AbbVie Inc. |
| Substance Name | CYCLOSPORINE |
| Active Ingredient Strength | 100 mg/mL |
| Pharm Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 0074-7269-50
1 BOTTLE in 1 CARTON (0074-7269-50) > 50 mL in 1 BOTTLE
| Marketing Start Date | 2010-05-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0074-7269-50 [00074726950]
Gengraf SOLUTION
| Marketing Category | ANDA |
| Application Number | ANDA065025 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-05-25 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| CYCLOSPORINE | 100 mg/mL |
OpenFDA Data
| SPL SET ID: | 29891f95-9079-4880-7abc-194e49767dd5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Calcineurin Inhibitor Immunosuppressant [EPC]
- Calcineurin Inhibitors [MoA]
- Cytochrome P450 3A4 Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
NDC Crossover Matching brand name "Gengraf" or generic name "Cyclosporine"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0074-3108 | Gengraf | Cyclosporine |
| 0074-3109 | Gengraf | Cyclosporine |
| 0074-7269 | Gengraf | Cyclosporine |
| 0078-0246 | Neoral | cyclosporine |
| 0078-0248 | Neoral | cyclosporine |
| 0023-9163 | RESTASIS | cyclosporine |
| 0023-5301 | Restasis MultiDose | cyclosporine |
| 0078-0109 | Sandimmune | cyclosporine |
| 0078-0110 | Sandimmune | cyclosporine |
| 0078-0240 | Sandimmune | cyclosporine |
| 0078-0241 | Sandimmune | cyclosporine |
Trademark Results [Gengraf]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 GENGRAF 75387943 2441241 Live/Registered |
ABBVIE INC. 1997-11-10 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.